[Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000494:pharmacology; D000779:Anesthetics, Local; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004357:Drug Synergism; D004569:Electroencephalography; D005769:Gastrointestinal Motility / Q000187:drug effects; D006016:Glycolates / Q000494:pharmacology; D006168:Guinea Pigs; D006220:Haloperidol / Q000037:antagonists & inhibitors; D000882:Haplorhini; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009469:Neuromuscular Junction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010276:Parasympatholytics / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010830:Physostigmine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects; D011817:Rabbits; D012110:Reserpine / Q000037:antagonists & inhibitors; D012119:Respiration / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D013876:Thiophenes / Q000494:pharmacology*; D014202:Tremor / Q000139:chemically induced; D014203:Tremorine / Q000037:antagonists & inhibitors
D000700:Analgesics; D000779:Anesthetics, Local; D000927:Anticonvulsants; D001463:Barbiturates; D006016:Glycolates; D006571:Heterocyclic Compounds; D010276:Parasympatholytics; D013876:Thiophenes; D012110:Reserpine; D010830:Physostigmine; D006220:Haloperidol; D000109:Acetylcholine; D014203:Tremorine